# expert reaction to a retrospective cohort study looking at GLP-1 RA discontinuation and cardiovascular events and all-cause mortality in people with type 2 diabetes

Source: [Science Media Centre](https://www.sciencemediacentre.org/expert-reaction-to-a-retrospective-cohort-study-looking-at-glp-1-ra-discontinuation-and-cardiovascular-events-and-all-cause-mortality-in-people-with-type-2-diabetes/) · 2026-11-09 · Science & Society
Page: https://themorning.science/story/expert-reaction-to-a-retrospective-cohort-study-looking-at-glp-1-ra-discontinuat-72dca52c6b28f313
Kind: research · Impact: medium

## In brief

- A retrospective cohort study in The Lancet Regional Health – Europe examines GLP-1 receptor agonist discontinuation in people with type 2 diabetes.
- The study looks at cardiovascular events and all-cause mortality associated with stopping these drugs.
- A Science Media Centre expert reaction to the study was published on 2026-11-10.

## Why it matters

Clinicians and patients weigh whether to continue or stop GLP-1 receptor agonists, so an association between stopping and cardiovascular outcomes bears on that decision. Retrospective cohort designs show associations rather than proof of cause, so readers should check the study's details.

## Coverage

- [expert reaction to a retrospective cohort study looking at GLP-1 RA discontinuation and cardiovascular events and all-cause mortality in people with type 2 diabetes](https://www.sciencemediacentre.org/expert-reaction-to-a-retrospective-cohort-study-looking-at-glp-1-ra-discontinuation-and-cardiovascular-events-and-all-cause-mortality-in-people-with-type-2-diabetes/) — Science Media Centre, 2026-11-09

Tags: glp-1, type-2-diabetes, cardiovascular, mortality, retrospective-study

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science